nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Glutamine—TGM2—brain cancer	0.781	1	CbGaD
L-Glutamine—F13A1—Alpha9 beta1 integrin signaling events—TGM2—brain cancer	0.00293	0.107	CbGpPWpGaD
L-Glutamine—TGM2—endothelium—brain cancer	0.00277	0.0219	CbGeAlD
L-Glutamine—TGM2—blood vessel—brain cancer	0.00256	0.0202	CbGeAlD
L-Glutamine—L-Cysteine—MGMT—brain cancer	0.00248	1	CrCbGaD
L-Glutamine—GMPS—hindbrain—brain cancer	0.0023	0.0182	CbGeAlD
L-Glutamine—TGM4—endocrine gland—brain cancer	0.0019	0.0151	CbGeAlD
L-Glutamine—TGM2—Alpha9 beta1 integrin signaling events—SPP1—brain cancer	0.00161	0.0586	CbGpPWpGaD
L-Glutamine—SLC7A8—Basigin interactions—BSG—brain cancer	0.0016	0.0582	CbGpPWpGaD
L-Glutamine—TGM5—spinal cord—brain cancer	0.00147	0.0116	CbGeAlD
L-Glutamine—GLS2—telencephalon—brain cancer	0.00145	0.0115	CbGeAlD
L-Glutamine—GLS—brainstem—brain cancer	0.00141	0.0112	CbGeAlD
L-Glutamine—GLUL—ganglion—brain cancer	0.00141	0.0111	CbGeAlD
L-Glutamine—F13A1—Beta1 integrin cell surface interactions—TGM2—brain cancer	0.00135	0.0492	CbGpPWpGaD
L-Glutamine—Haemorrhoids—Temozolomide—brain cancer	0.00135	0.0215	CcSEcCtD
L-Glutamine—GATB—telencephalon—brain cancer	0.00133	0.0105	CbGeAlD
L-Glutamine—GMPS—brainstem—brain cancer	0.00132	0.0104	CbGeAlD
L-Glutamine—GLS—telencephalon—brain cancer	0.00125	0.00991	CbGeAlD
L-Glutamine—Anorectal discomfort—Etoposide—brain cancer	0.00116	0.0185	CcSEcCtD
L-Glutamine—PFAS—telencephalon—brain cancer	0.00115	0.00907	CbGeAlD
L-Glutamine—NADSYN1—medulla oblongata—brain cancer	0.00114	0.00901	CbGeAlD
L-Glutamine—Hepatic function abnormal—Procarbazine—brain cancer	0.00109	0.0174	CcSEcCtD
L-Glutamine—F13A1—Alpha9 beta1 integrin signaling events—SPP1—brain cancer	0.00109	0.0396	CbGpPWpGaD
L-Glutamine—CCBL1—pituitary gland—brain cancer	0.00108	0.00857	CbGeAlD
L-Glutamine—GLUL—hindbrain—brain cancer	0.00107	0.00844	CbGeAlD
L-Glutamine—TGM1—head—brain cancer	0.00105	0.00833	CbGeAlD
L-Glutamine—GLS—gonad—brain cancer	0.00105	0.00827	CbGeAlD
L-Glutamine—CCBL1—medulla oblongata—brain cancer	0.00105	0.00827	CbGeAlD
L-Glutamine—GLS2—midbrain—brain cancer	0.00104	0.00824	CbGeAlD
L-Glutamine—TGM2—gonad—brain cancer	0.00104	0.00818	CbGeAlD
L-Glutamine—Injection site pain—Carmustine—brain cancer	0.001	0.016	CcSEcCtD
L-Glutamine—TGM3—endocrine gland—brain cancer	0.001	0.00791	CbGeAlD
L-Glutamine—TGM3—head—brain cancer	0.000988	0.00781	CbGeAlD
L-Glutamine—QARS—telencephalon—brain cancer	0.000978	0.00773	CbGeAlD
L-Glutamine—Nail disorder—Etoposide—brain cancer	0.000978	0.0156	CcSEcCtD
L-Glutamine—GMPS—gonad—brain cancer	0.000975	0.00771	CbGeAlD
L-Glutamine—CTPS1—gonad—brain cancer	0.000975	0.00771	CbGeAlD
L-Glutamine—Rigors—Temozolomide—brain cancer	0.000971	0.0155	CcSEcCtD
L-Glutamine—GFPT2—gonad—brain cancer	0.000957	0.00757	CbGeAlD
L-Glutamine—PFAS—gonad—brain cancer	0.000957	0.00757	CbGeAlD
L-Glutamine—GATB—midbrain—brain cancer	0.000956	0.00756	CbGeAlD
L-Glutamine—CCBL1—midbrain—brain cancer	0.000956	0.00756	CbGeAlD
L-Glutamine—CTPS1—pituitary gland—brain cancer	0.000951	0.00752	CbGeAlD
L-Glutamine—GMPS—pituitary gland—brain cancer	0.000951	0.00752	CbGeAlD
L-Glutamine—PFAS—pituitary gland—brain cancer	0.000934	0.00738	CbGeAlD
L-Glutamine—GFPT2—pituitary gland—brain cancer	0.000934	0.00738	CbGeAlD
L-Glutamine—CCBL1—spinal cord—brain cancer	0.000933	0.00737	CbGeAlD
L-Glutamine—CTPS1—medulla oblongata—brain cancer	0.000918	0.00726	CbGeAlD
L-Glutamine—GMPS—medulla oblongata—brain cancer	0.000918	0.00726	CbGeAlD
L-Glutamine—GLS2—endocrine gland—brain cancer	0.000915	0.00724	CbGeAlD
L-Glutamine—NADSYN1—endocrine gland—brain cancer	0.000915	0.00724	CbGeAlD
L-Glutamine—Breast pain—Temozolomide—brain cancer	0.000908	0.0145	CcSEcCtD
L-Glutamine—NADSYN1—head—brain cancer	0.000903	0.00714	CbGeAlD
L-Glutamine—GLS2—head—brain cancer	0.000903	0.00714	CbGeAlD
L-Glutamine—TGM3—central nervous system—brain cancer	0.000902	0.00713	CbGeAlD
L-Glutamine—PFAS—medulla oblongata—brain cancer	0.000901	0.00712	CbGeAlD
L-Glutamine—GFPT2—medulla oblongata—brain cancer	0.000901	0.00712	CbGeAlD
L-Glutamine—Viral infection—Temozolomide—brain cancer	0.000877	0.014	CcSEcCtD
L-Glutamine—F13A1—gonad—brain cancer	0.000859	0.00679	CbGeAlD
L-Glutamine—GMPS—midbrain—brain cancer	0.000839	0.00663	CbGeAlD
L-Glutamine—F13A1—pituitary gland—brain cancer	0.000838	0.00662	CbGeAlD
L-Glutamine—Infection—Carboplatin—brain cancer	0.000836	0.0134	CcSEcCtD
L-Glutamine—CCBL1—head—brain cancer	0.000829	0.00655	CbGeAlD
L-Glutamine—GATB—head—brain cancer	0.000829	0.00655	CbGeAlD
L-Glutamine—GLS2—central nervous system—brain cancer	0.000825	0.00652	CbGeAlD
L-Glutamine—NADSYN1—central nervous system—brain cancer	0.000825	0.00652	CbGeAlD
L-Glutamine—GFPT2—midbrain—brain cancer	0.000824	0.00651	CbGeAlD
L-Glutamine—PFAS—midbrain—brain cancer	0.000824	0.00651	CbGeAlD
L-Glutamine—GMPS—spinal cord—brain cancer	0.000818	0.00647	CbGeAlD
L-Glutamine—QARS—gonad—brain cancer	0.000816	0.00645	CbGeAlD
L-Glutamine—Injection site reaction—Carmustine—brain cancer	0.000815	0.013	CcSEcCtD
L-Glutamine—F13A1—medulla oblongata—brain cancer	0.000809	0.00639	CbGeAlD
L-Glutamine—Pancreatitis—Procarbazine—brain cancer	0.000806	0.0129	CcSEcCtD
L-Glutamine—NADSYN1—cerebellum—brain cancer	0.000806	0.00637	CbGeAlD
L-Glutamine—GLS2—cerebellum—brain cancer	0.000806	0.00637	CbGeAlD
L-Glutamine—PFAS—spinal cord—brain cancer	0.000804	0.00635	CbGeAlD
L-Glutamine—GFPT2—spinal cord—brain cancer	0.000804	0.00635	CbGeAlD
L-Glutamine—Sweating increased—Procarbazine—brain cancer	0.000801	0.0128	CcSEcCtD
L-Glutamine—QARS—pituitary gland—brain cancer	0.000796	0.0063	CbGeAlD
L-Glutamine—GLS—endocrine gland—brain cancer	0.000791	0.00625	CbGeAlD
L-Glutamine—Candida infection—Carmustine—brain cancer	0.000783	0.0125	CcSEcCtD
L-Glutamine—TGM2—endocrine gland—brain cancer	0.000782	0.00619	CbGeAlD
L-Glutamine—GLS—head—brain cancer	0.000781	0.00617	CbGeAlD
L-Glutamine—Rigors—Etoposide—brain cancer	0.000777	0.0124	CcSEcCtD
L-Glutamine—TGM2—head—brain cancer	0.000772	0.00611	CbGeAlD
L-Glutamine—QARS—medulla oblongata—brain cancer	0.000769	0.00608	CbGeAlD
L-Glutamine—TGM2—Alpha9 beta1 integrin signaling events—VEGFA—brain cancer	0.000767	0.028	CbGpPWpGaD
L-Glutamine—CCBL1—central nervous system—brain cancer	0.000757	0.00598	CbGeAlD
L-Glutamine—GATB—central nervous system—brain cancer	0.000757	0.00598	CbGeAlD
L-Glutamine—Candida infection—Temozolomide—brain cancer	0.000757	0.0121	CcSEcCtD
L-Glutamine—CAD—gonad—brain cancer	0.000753	0.00595	CbGeAlD
L-Glutamine—SLC38A3—brain—brain cancer	0.000747	0.0059	CbGeAlD
L-Glutamine—CCBL1—cerebellum—brain cancer	0.00074	0.00585	CbGeAlD
L-Glutamine—GATB—cerebellum—brain cancer	0.00074	0.00585	CbGeAlD
L-Glutamine—F13A1—midbrain—brain cancer	0.000739	0.00584	CbGeAlD
L-Glutamine—TGM2—Beta1 integrin cell surface interactions—SPP1—brain cancer	0.000739	0.0269	CbGpPWpGaD
L-Glutamine—GMPS—endocrine gland—brain cancer	0.000737	0.00582	CbGeAlD
L-Glutamine—CTPS1—endocrine gland—brain cancer	0.000737	0.00582	CbGeAlD
L-Glutamine—CAD—pituitary gland—brain cancer	0.000735	0.00581	CbGeAlD
L-Glutamine—Infection—Lomustine—brain cancer	0.000732	0.0117	CcSEcCtD
L-Glutamine—GMPS—head—brain cancer	0.000727	0.00575	CbGeAlD
L-Glutamine—CTPS1—head—brain cancer	0.000727	0.00575	CbGeAlD
L-Glutamine—PFAS—endocrine gland—brain cancer	0.000723	0.00572	CbGeAlD
L-Glutamine—GFPT2—endocrine gland—brain cancer	0.000723	0.00572	CbGeAlD
L-Glutamine—F13A1—spinal cord—brain cancer	0.000721	0.0057	CbGeAlD
L-Glutamine—Pain—Carboplatin—brain cancer	0.00072	0.0115	CcSEcCtD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—MPL—brain cancer	0.00072	0.0263	CbGpPWpGaD
L-Glutamine—Neuropathy peripheral—Procarbazine—brain cancer	0.000719	0.0115	CcSEcCtD
L-Glutamine—TGM3—brain—brain cancer	0.000716	0.00566	CbGeAlD
L-Glutamine—PFAS—head—brain cancer	0.000714	0.00565	CbGeAlD
L-Glutamine—GLS—central nervous system—brain cancer	0.000713	0.00564	CbGeAlD
L-Glutamine—Sepsis—Carmustine—brain cancer	0.000712	0.0114	CcSEcCtD
L-Glutamine—TGM2—central nervous system—brain cancer	0.000705	0.00557	CbGeAlD
L-Glutamine—QARS—midbrain—brain cancer	0.000702	0.00555	CbGeAlD
L-Glutamine—PPAT—gonad—brain cancer	0.000698	0.00552	CbGeAlD
L-Glutamine—SLC7A8—telencephalon—brain cancer	0.000698	0.00551	CbGeAlD
L-Glutamine—GLS—cerebellum—brain cancer	0.000697	0.00551	CbGeAlD
L-Glutamine—QARS—spinal cord—brain cancer	0.000685	0.00542	CbGeAlD
L-Glutamine—PPAT—pituitary gland—brain cancer	0.000681	0.00539	CbGeAlD
L-Glutamine—TGM2—Thromboxane A2 receptor signaling—PIK3CG—brain cancer	0.000673	0.0245	CbGpPWpGaD
L-Glutamine—Body temperature increased—Carboplatin—brain cancer	0.000666	0.0106	CcSEcCtD
L-Glutamine—ASNS—telencephalon—brain cancer	0.000665	0.00525	CbGeAlD
L-Glutamine—GMPS—central nervous system—brain cancer	0.000664	0.00525	CbGeAlD
L-Glutamine—CTPS1—central nervous system—brain cancer	0.000664	0.00525	CbGeAlD
L-Glutamine—PPAT—medulla oblongata—brain cancer	0.000657	0.0052	CbGeAlD
L-Glutamine—NADSYN1—brain—brain cancer	0.000655	0.00518	CbGeAlD
L-Glutamine—GLS2—brain—brain cancer	0.000655	0.00518	CbGeAlD
L-Glutamine—PFAS—central nervous system—brain cancer	0.000652	0.00515	CbGeAlD
L-Glutamine—F13A1—endocrine gland—brain cancer	0.000649	0.00513	CbGeAlD
L-Glutamine—CTPS1—cerebellum—brain cancer	0.000649	0.00513	CbGeAlD
L-Glutamine—GMPS—cerebellum—brain cancer	0.000649	0.00513	CbGeAlD
L-Glutamine—CAD—midbrain—brain cancer	0.000648	0.00512	CbGeAlD
L-Glutamine—F13A1—head—brain cancer	0.000641	0.00507	CbGeAlD
L-Glutamine—GFPT2—cerebellum—brain cancer	0.000637	0.00504	CbGeAlD
L-Glutamine—PFAS—cerebellum—brain cancer	0.000637	0.00504	CbGeAlD
L-Glutamine—CAD—spinal cord—brain cancer	0.000632	0.005	CbGeAlD
L-Glutamine—SLC1A5—pituitary gland—brain cancer	0.000631	0.00499	CbGeAlD
L-Glutamine—Pancreatitis—Hydroxyurea—brain cancer	0.000624	0.00996	CcSEcCtD
L-Glutamine—QARS—endocrine gland—brain cancer	0.000617	0.00488	CbGeAlD
L-Glutamine—GLUL—brainstem—brain cancer	0.000612	0.00484	CbGeAlD
L-Glutamine—QARS—head—brain cancer	0.000609	0.00482	CbGeAlD
L-Glutamine—SLC1A5—medulla oblongata—brain cancer	0.000609	0.00481	CbGeAlD
L-Glutamine—Candida infection—Etoposide—brain cancer	0.000605	0.00967	CcSEcCtD
L-Glutamine—Thirst—Temozolomide—brain cancer	0.000604	0.00965	CcSEcCtD
L-Glutamine—PPAT—midbrain—brain cancer	0.000601	0.00475	CbGeAlD
L-Glutamine—GATB—brain—brain cancer	0.000601	0.00475	CbGeAlD
L-Glutamine—CCBL1—brain—brain cancer	0.000601	0.00475	CbGeAlD
L-Glutamine—Chills—Procarbazine—brain cancer	0.000591	0.00943	CcSEcCtD
L-Glutamine—PPAT—spinal cord—brain cancer	0.000586	0.00463	CbGeAlD
L-Glutamine—F13A1—central nervous system—brain cancer	0.000585	0.00462	CbGeAlD
L-Glutamine—Body temperature increased—Lomustine—brain cancer	0.000582	0.0093	CcSEcCtD
L-Glutamine—SLC7A8—gonad—brain cancer	0.000582	0.0046	CbGeAlD
L-Glutamine—F13A1—cerebellum—brain cancer	0.000572	0.00452	CbGeAlD
L-Glutamine—CAD—endocrine gland—brain cancer	0.000569	0.0045	CbGeAlD
L-Glutamine—SLC7A8—pituitary gland—brain cancer	0.000568	0.00449	CbGeAlD
L-Glutamine—GLS—brain—brain cancer	0.000566	0.00447	CbGeAlD
L-Glutamine—CAD—head—brain cancer	0.000562	0.00444	CbGeAlD
L-Glutamine—TGM2—brain—brain cancer	0.00056	0.00442	CbGeAlD
L-Glutamine—SLC1A5—midbrain—brain cancer	0.000556	0.0044	CbGeAlD
L-Glutamine—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000556	0.00888	CcSEcCtD
L-Glutamine—QARS—central nervous system—brain cancer	0.000556	0.0044	CbGeAlD
L-Glutamine—Sepsis—Etoposide—brain cancer	0.00055	0.00879	CcSEcCtD
L-Glutamine—QARS—cerebellum—brain cancer	0.000543	0.0043	CbGeAlD
L-Glutamine—GLUL—telencephalon—brain cancer	0.000543	0.00429	CbGeAlD
L-Glutamine—SLC1A5—spinal cord—brain cancer	0.000543	0.00429	CbGeAlD
L-Glutamine—ASNS—pituitary gland—brain cancer	0.000541	0.00428	CbGeAlD
L-Glutamine—Dehydration—Temozolomide—brain cancer	0.000535	0.00854	CcSEcCtD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—BSG—brain cancer	0.000531	0.0194	CbGpPWpGaD
L-Glutamine—PPAT—endocrine gland—brain cancer	0.000528	0.00417	CbGeAlD
L-Glutamine—CTPS1—brain—brain cancer	0.000527	0.00417	CbGeAlD
L-Glutamine—GMPS—brain—brain cancer	0.000527	0.00417	CbGeAlD
L-Glutamine—ASNS—medulla oblongata—brain cancer	0.000522	0.00413	CbGeAlD
L-Glutamine—PPAT—head—brain cancer	0.000521	0.00412	CbGeAlD
L-Glutamine—F13A1—Alpha9 beta1 integrin signaling events—VEGFA—brain cancer	0.000518	0.0189	CbGpPWpGaD
L-Glutamine—PFAS—brain—brain cancer	0.000518	0.00409	CbGeAlD
L-Glutamine—GFPT2—brain—brain cancer	0.000518	0.00409	CbGeAlD
L-Glutamine—CAD—cerebellum—brain cancer	0.000501	0.00396	CbGeAlD
L-Glutamine—Abdominal distension—Temozolomide—brain cancer	0.0005	0.00799	CcSEcCtD
L-Glutamine—F13A1—Beta1 integrin cell surface interactions—SPP1—brain cancer	0.000499	0.0182	CbGpPWpGaD
L-Glutamine—SLC1A5—endocrine gland—brain cancer	0.000489	0.00386	CbGeAlD
L-Glutamine—Myalgia—Procarbazine—brain cancer	0.000488	0.00779	CcSEcCtD
L-Glutamine—Arthralgia—Procarbazine—brain cancer	0.000488	0.00779	CcSEcCtD
L-Glutamine—Sweating increased—Temozolomide—brain cancer	0.000484	0.00773	CcSEcCtD
L-Glutamine—SLC1A5—head—brain cancer	0.000482	0.00381	CbGeAlD
L-Glutamine—ASNS—midbrain—brain cancer	0.000477	0.00377	CbGeAlD
L-Glutamine—Dry mouth—Procarbazine—brain cancer	0.000477	0.00762	CcSEcCtD
L-Glutamine—PPAT—central nervous system—brain cancer	0.000476	0.00376	CbGeAlD
L-Glutamine—Vomiting—Lomustine—brain cancer	0.000468	0.00748	CcSEcCtD
L-Glutamine—Oedema—Procarbazine—brain cancer	0.000468	0.00747	CcSEcCtD
L-Glutamine—ASNS—spinal cord—brain cancer	0.000466	0.00368	CbGeAlD
L-Glutamine—PPAT—cerebellum—brain cancer	0.000465	0.00367	CbGeAlD
L-Glutamine—Infection—Procarbazine—brain cancer	0.000465	0.00742	CcSEcCtD
L-Glutamine—F13A1—brain—brain cancer	0.000464	0.00367	CbGeAlD
L-Glutamine—Angiopathy—Hydroxyurea—brain cancer	0.000462	0.00738	CcSEcCtD
L-Glutamine—Depression—Carmustine—brain cancer	0.000457	0.0073	CcSEcCtD
L-Glutamine—Chills—Hydroxyurea—brain cancer	0.000457	0.0073	CcSEcCtD
L-Glutamine—GLUL—gonad—brain cancer	0.000453	0.00358	CbGeAlD
L-Glutamine—Hyperhidrosis—Procarbazine—brain cancer	0.000452	0.00722	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Carmustine—brain cancer	0.00045	0.00718	CcSEcCtD
L-Glutamine—Depression—Temozolomide—brain cancer	0.000442	0.00706	CcSEcCtD
L-Glutamine—GLUL—pituitary gland—brain cancer	0.000442	0.00349	CbGeAlD
L-Glutamine—QARS—brain—brain cancer	0.000441	0.00349	CbGeAlD
L-Glutamine—SLC1A5—central nervous system—brain cancer	0.00044	0.00348	CbGeAlD
L-Glutamine—SLC7A8—endocrine gland—brain cancer	0.00044	0.00348	CbGeAlD
L-Glutamine—Nausea—Lomustine—brain cancer	0.000437	0.00699	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Temozolomide—brain cancer	0.000435	0.00694	CcSEcCtD
L-Glutamine—SLC7A8—head—brain cancer	0.000434	0.00343	CbGeAlD
L-Glutamine—SLC1A5—cerebellum—brain cancer	0.00043	0.0034	CbGeAlD
L-Glutamine—GLUL—medulla oblongata—brain cancer	0.000427	0.00337	CbGeAlD
L-Glutamine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000426	0.0068	CcSEcCtD
L-Glutamine—Insomnia—Procarbazine—brain cancer	0.000423	0.00675	CcSEcCtD
L-Glutamine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000411	0.00657	CcSEcCtD
L-Glutamine—CAD—brain—brain cancer	0.000407	0.00322	CbGeAlD
L-Glutamine—Fatigue—Procarbazine—brain cancer	0.000403	0.00644	CcSEcCtD
L-Glutamine—Malaise—Hydroxyurea—brain cancer	0.0004	0.00639	CcSEcCtD
L-Glutamine—Pain—Procarbazine—brain cancer	0.0004	0.00639	CcSEcCtD
L-Glutamine—Constipation—Procarbazine—brain cancer	0.0004	0.00639	CcSEcCtD
L-Glutamine—SLC7A8—central nervous system—brain cancer	0.000396	0.00313	CbGeAlD
L-Glutamine—Pharyngitis—Temozolomide—brain cancer	0.000395	0.00631	CcSEcCtD
L-Glutamine—Urinary tract disorder—Temozolomide—brain cancer	0.000393	0.00628	CcSEcCtD
L-Glutamine—Urethral disorder—Temozolomide—brain cancer	0.00039	0.00623	CcSEcCtD
L-Glutamine—GLUL—midbrain—brain cancer	0.00039	0.00308	CbGeAlD
L-Glutamine—Sweating increased—Etoposide—brain cancer	0.000388	0.00619	CcSEcCtD
L-Glutamine—SLC7A8—cerebellum—brain cancer	0.000388	0.00306	CbGeAlD
L-Glutamine—Feeling abnormal—Procarbazine—brain cancer	0.000385	0.00615	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Procarbazine—brain cancer	0.000382	0.00611	CcSEcCtD
L-Glutamine—GLUL—spinal cord—brain cancer	0.00038	0.00301	CbGeAlD
L-Glutamine—PPAT—brain—brain cancer	0.000378	0.00298	CbGeAlD
L-Glutamine—Discomfort—Hydroxyurea—brain cancer	0.000373	0.00596	CcSEcCtD
L-Glutamine—F13A1—Hemostasis—MPL—brain cancer	0.000371	0.0135	CbGpPWpGaD
L-Glutamine—Abdominal pain—Procarbazine—brain cancer	0.00037	0.0059	CcSEcCtD
L-Glutamine—Body temperature increased—Procarbazine—brain cancer	0.00037	0.0059	CcSEcCtD
L-Glutamine—ASNS—cerebellum—brain cancer	0.000369	0.00292	CbGeAlD
L-Glutamine—TGM2—Thromboxane A2 receptor signaling—EGFR—brain cancer	0.000362	0.0132	CbGpPWpGaD
L-Glutamine—Oedema—Hydroxyurea—brain cancer	0.000362	0.00578	CcSEcCtD
L-Glutamine—Angiopathy—Temozolomide—brain cancer	0.000361	0.00577	CcSEcCtD
L-Glutamine—Mental disorder—Carmustine—brain cancer	0.000361	0.00576	CcSEcCtD
L-Glutamine—Infection—Hydroxyurea—brain cancer	0.00036	0.00574	CcSEcCtD
L-Glutamine—Malnutrition—Carmustine—brain cancer	0.000358	0.00572	CcSEcCtD
L-Glutamine—Chills—Temozolomide—brain cancer	0.000357	0.0057	CcSEcCtD
L-Glutamine—F13A1—Hemostasis—S100A10—brain cancer	0.000356	0.013	CbGpPWpGaD
L-Glutamine—TGM2—Beta1 integrin cell surface interactions—VEGFA—brain cancer	0.000353	0.0129	CbGpPWpGaD
L-Glutamine—SLC1A5—brain—brain cancer	0.00035	0.00276	CbGeAlD
L-Glutamine—Mental disorder—Temozolomide—brain cancer	0.000349	0.00557	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Etoposide—brain cancer	0.000348	0.00555	CcSEcCtD
L-Glutamine—Back pain—Carmustine—brain cancer	0.000347	0.00554	CcSEcCtD
L-Glutamine—Malnutrition—Temozolomide—brain cancer	0.000346	0.00553	CcSEcCtD
L-Glutamine—SLC16A10—gonad—brain cancer	0.000345	0.00273	CbGeAlD
L-Glutamine—Hypersensitivity—Procarbazine—brain cancer	0.000345	0.0055	CcSEcCtD
L-Glutamine—GLUL—endocrine gland—brain cancer	0.000342	0.00271	CbGeAlD
L-Glutamine—GLUL—head—brain cancer	0.000338	0.00267	CbGeAlD
L-Glutamine—Asthenia—Procarbazine—brain cancer	0.000335	0.00536	CcSEcCtD
L-Glutamine—Back pain—Temozolomide—brain cancer	0.000335	0.00535	CcSEcCtD
L-Glutamine—Pruritus—Procarbazine—brain cancer	0.000331	0.00528	CcSEcCtD
L-Glutamine—Ill-defined disorder—Temozolomide—brain cancer	0.000321	0.00513	CcSEcCtD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—TRPC6—brain cancer	0.000319	0.0116	CbGpPWpGaD
L-Glutamine—SLC7A8—brain—brain cancer	0.000315	0.00249	CbGeAlD
L-Glutamine—Urinary tract disorder—Etoposide—brain cancer	0.000314	0.00502	CcSEcCtD
L-Glutamine—Malaise—Temozolomide—brain cancer	0.000312	0.00499	CcSEcCtD
L-Glutamine—Urethral disorder—Etoposide—brain cancer	0.000312	0.00498	CcSEcCtD
L-Glutamine—Fatigue—Hydroxyurea—brain cancer	0.000312	0.00498	CcSEcCtD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—CDK4—brain cancer	0.000312	0.0114	CbGpPWpGaD
L-Glutamine—Pain—Hydroxyurea—brain cancer	0.000309	0.00494	CcSEcCtD
L-Glutamine—Constipation—Hydroxyurea—brain cancer	0.000309	0.00494	CcSEcCtD
L-Glutamine—Dizziness—Procarbazine—brain cancer	0.000309	0.00494	CcSEcCtD
L-Glutamine—GLUL—central nervous system—brain cancer	0.000309	0.00244	CbGeAlD
L-Glutamine—Chest pain—Carmustine—brain cancer	0.000305	0.00487	CcSEcCtD
L-Glutamine—Myalgia—Carmustine—brain cancer	0.000305	0.00487	CcSEcCtD
L-Glutamine—GLUL—cerebellum—brain cancer	0.000302	0.00238	CbGeAlD
L-Glutamine—ASNS—brain—brain cancer	0.0003	0.00237	CbGeAlD
L-Glutamine—Feeling abnormal—Hydroxyurea—brain cancer	0.000298	0.00476	CcSEcCtD
L-Glutamine—Vomiting—Procarbazine—brain cancer	0.000297	0.00475	CcSEcCtD
L-Glutamine—Arthralgia—Temozolomide—brain cancer	0.000295	0.00471	CcSEcCtD
L-Glutamine—Myalgia—Temozolomide—brain cancer	0.000295	0.00471	CcSEcCtD
L-Glutamine—Rash—Procarbazine—brain cancer	0.000295	0.00471	CcSEcCtD
L-Glutamine—Dermatitis—Procarbazine—brain cancer	0.000295	0.0047	CcSEcCtD
L-Glutamine—Headache—Procarbazine—brain cancer	0.000293	0.00468	CcSEcCtD
L-Glutamine—Oedema—Carmustine—brain cancer	0.000293	0.00467	CcSEcCtD
L-Glutamine—Discomfort—Temozolomide—brain cancer	0.000291	0.00465	CcSEcCtD
L-Glutamine—Infection—Carmustine—brain cancer	0.000291	0.00464	CcSEcCtD
L-Glutamine—Angiopathy—Etoposide—brain cancer	0.000289	0.00461	CcSEcCtD
L-Glutamine—Dry mouth—Temozolomide—brain cancer	0.000288	0.00461	CcSEcCtD
L-Glutamine—Body temperature increased—Hydroxyurea—brain cancer	0.000286	0.00457	CcSEcCtD
L-Glutamine—Chills—Etoposide—brain cancer	0.000286	0.00456	CcSEcCtD
L-Glutamine—Oedema—Temozolomide—brain cancer	0.000283	0.00451	CcSEcCtD
L-Glutamine—SLC1A5—Transmembrane transport of small molecules—S100A10—brain cancer	0.000282	0.0103	CbGpPWpGaD
L-Glutamine—Infection—Temozolomide—brain cancer	0.000281	0.00448	CcSEcCtD
L-Glutamine—Nausea—Procarbazine—brain cancer	0.000278	0.00444	CcSEcCtD
L-Glutamine—Hyperhidrosis—Temozolomide—brain cancer	0.000273	0.00436	CcSEcCtD
L-Glutamine—Back pain—Etoposide—brain cancer	0.000268	0.00428	CcSEcCtD
L-Glutamine—Hypersensitivity—Hydroxyurea—brain cancer	0.000267	0.00426	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000267	0.00426	CcSEcCtD
L-Glutamine—Insomnia—Carmustine—brain cancer	0.000265	0.00423	CcSEcCtD
L-Glutamine—SLC16A10—endocrine gland—brain cancer	0.000261	0.00206	CbGeAlD
L-Glutamine—Asthenia—Hydroxyurea—brain cancer	0.00026	0.00415	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000258	0.00411	CcSEcCtD
L-Glutamine—Ill-defined disorder—Etoposide—brain cancer	0.000257	0.00411	CcSEcCtD
L-Glutamine—Insomnia—Temozolomide—brain cancer	0.000256	0.00408	CcSEcCtD
L-Glutamine—NADSYN1—Disease—DTX2—brain cancer	0.000255	0.0093	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—BSG—brain cancer	0.000251	0.00914	CbGpPWpGaD
L-Glutamine—Constipation—Carmustine—brain cancer	0.00025	0.00399	CcSEcCtD
L-Glutamine—Pain—Carmustine—brain cancer	0.00025	0.00399	CcSEcCtD
L-Glutamine—Malaise—Etoposide—brain cancer	0.00025	0.00399	CcSEcCtD
L-Glutamine—GLUL—brain—brain cancer	0.000245	0.00194	CbGeAlD
L-Glutamine—PPAT—Fluoropyrimidine Activity—TP53—brain cancer	0.000244	0.0089	CbGpPWpGaD
L-Glutamine—Fatigue—Temozolomide—brain cancer	0.000244	0.00389	CcSEcCtD
L-Glutamine—Constipation—Temozolomide—brain cancer	0.000242	0.00386	CcSEcCtD
L-Glutamine—Pain—Temozolomide—brain cancer	0.000242	0.00386	CcSEcCtD
L-Glutamine—Feeling abnormal—Carmustine—brain cancer	0.000241	0.00385	CcSEcCtD
L-Glutamine—SLC38A3—Transmembrane transport of small molecules—S100A10—brain cancer	0.000239	0.00873	CbGpPWpGaD
L-Glutamine—Dizziness—Hydroxyurea—brain cancer	0.000239	0.00382	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Carmustine—brain cancer	0.000239	0.00382	CcSEcCtD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—VAV1—brain cancer	0.000239	0.00871	CbGpPWpGaD
L-Glutamine—F13A1—Beta1 integrin cell surface interactions—VEGFA—brain cancer	0.000238	0.0087	CbGpPWpGaD
L-Glutamine—Chest pain—Etoposide—brain cancer	0.000236	0.00377	CcSEcCtD
L-Glutamine—Discomfort—Etoposide—brain cancer	0.000233	0.00372	CcSEcCtD
L-Glutamine—Feeling abnormal—Temozolomide—brain cancer	0.000233	0.00372	CcSEcCtD
L-Glutamine—Body temperature increased—Carmustine—brain cancer	0.000231	0.00369	CcSEcCtD
L-Glutamine—Abdominal pain—Carmustine—brain cancer	0.000231	0.00369	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Temozolomide—brain cancer	0.000231	0.00369	CcSEcCtD
L-Glutamine—Vomiting—Hydroxyurea—brain cancer	0.00023	0.00367	CcSEcCtD
L-Glutamine—SLC16A10—cerebellum—brain cancer	0.00023	0.00182	CbGeAlD
L-Glutamine—Rash—Hydroxyurea—brain cancer	0.000228	0.00364	CcSEcCtD
L-Glutamine—Dermatitis—Hydroxyurea—brain cancer	0.000228	0.00364	CcSEcCtD
L-Glutamine—Headache—Hydroxyurea—brain cancer	0.000227	0.00362	CcSEcCtD
L-Glutamine—Infection—Etoposide—brain cancer	0.000225	0.00359	CcSEcCtD
L-Glutamine—Body temperature increased—Temozolomide—brain cancer	0.000223	0.00357	CcSEcCtD
L-Glutamine—Abdominal pain—Temozolomide—brain cancer	0.000223	0.00357	CcSEcCtD
L-Glutamine—CCBL1—Disease—DTX2—brain cancer	0.000223	0.00813	CbGpPWpGaD
L-Glutamine—Hyperhidrosis—Etoposide—brain cancer	0.000219	0.00349	CcSEcCtD
L-Glutamine—Hypersensitivity—Carmustine—brain cancer	0.000216	0.00344	CcSEcCtD
L-Glutamine—Nausea—Hydroxyurea—brain cancer	0.000215	0.00343	CcSEcCtD
L-Glutamine—SLC7A8—Hemostasis—MPL—brain cancer	0.000213	0.00777	CbGpPWpGaD
L-Glutamine—Asthenia—Carmustine—brain cancer	0.00021	0.00335	CcSEcCtD
L-Glutamine—Hypersensitivity—Temozolomide—brain cancer	0.000208	0.00333	CcSEcCtD
L-Glutamine—F13A1—Platelet degranulation—VEGFA—brain cancer	0.000204	0.00745	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—S100A10—brain cancer	0.000204	0.00745	CbGpPWpGaD
L-Glutamine—Asthenia—Temozolomide—brain cancer	0.000203	0.00324	CcSEcCtD
L-Glutamine—Pruritus—Temozolomide—brain cancer	0.0002	0.00319	CcSEcCtD
L-Glutamine—Fatigue—Etoposide—brain cancer	0.000195	0.00311	CcSEcCtD
L-Glutamine—F13A1—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	0.000195	0.0071	CbGpPWpGaD
L-Glutamine—Dizziness—Carmustine—brain cancer	0.000193	0.00309	CcSEcCtD
L-Glutamine—Pain—Etoposide—brain cancer	0.000193	0.00309	CcSEcCtD
L-Glutamine—Constipation—Etoposide—brain cancer	0.000193	0.00309	CcSEcCtD
L-Glutamine—NADSYN1—Disease—HES5—brain cancer	0.000187	0.00682	CbGpPWpGaD
L-Glutamine—Dizziness—Temozolomide—brain cancer	0.000187	0.00299	CcSEcCtD
L-Glutamine—Feeling abnormal—Etoposide—brain cancer	0.000186	0.00298	CcSEcCtD
L-Glutamine—Vomiting—Carmustine—brain cancer	0.000186	0.00297	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Etoposide—brain cancer	0.000185	0.00295	CcSEcCtD
L-Glutamine—Rash—Carmustine—brain cancer	0.000184	0.00295	CcSEcCtD
L-Glutamine—Dermatitis—Carmustine—brain cancer	0.000184	0.00294	CcSEcCtD
L-Glutamine—Headache—Carmustine—brain cancer	0.000183	0.00293	CcSEcCtD
L-Glutamine—Vomiting—Temozolomide—brain cancer	0.00018	0.00287	CcSEcCtD
L-Glutamine—Body temperature increased—Etoposide—brain cancer	0.000179	0.00286	CcSEcCtD
L-Glutamine—Abdominal pain—Etoposide—brain cancer	0.000179	0.00286	CcSEcCtD
L-Glutamine—Rash—Temozolomide—brain cancer	0.000178	0.00285	CcSEcCtD
L-Glutamine—Dermatitis—Temozolomide—brain cancer	0.000178	0.00284	CcSEcCtD
L-Glutamine—Headache—Temozolomide—brain cancer	0.000177	0.00283	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—CYP2C9—brain cancer	0.000177	0.00645	CbGpPWpGaD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—S100A10—brain cancer	0.000177	0.00645	CbGpPWpGaD
L-Glutamine—Nausea—Carmustine—brain cancer	0.000174	0.00277	CcSEcCtD
L-Glutamine—Nausea—Temozolomide—brain cancer	0.000168	0.00268	CcSEcCtD
L-Glutamine—Hypersensitivity—Etoposide—brain cancer	0.000167	0.00266	CcSEcCtD
L-Glutamine—F13A1—Hemostasis—TRPC6—brain cancer	0.000164	0.00599	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—HES5—brain cancer	0.000164	0.00596	CbGpPWpGaD
L-Glutamine—Asthenia—Etoposide—brain cancer	0.000162	0.00259	CcSEcCtD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—MYC—brain cancer	0.000162	0.00589	CbGpPWpGaD
L-Glutamine—Pruritus—Etoposide—brain cancer	0.00016	0.00256	CcSEcCtD
L-Glutamine—PFAS—Metabolism—CYP2C9—brain cancer	0.000158	0.00575	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—CYP2C9—brain cancer	0.000158	0.00575	CbGpPWpGaD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	0.000152	0.00553	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—BSG—brain cancer	0.00015	0.00549	CbGpPWpGaD
L-Glutamine—Dizziness—Etoposide—brain cancer	0.00015	0.00239	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—CYP2C9—brain cancer	0.000144	0.00526	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—BSG—brain cancer	0.000144	0.00525	CbGpPWpGaD
L-Glutamine—Vomiting—Etoposide—brain cancer	0.000144	0.0023	CcSEcCtD
L-Glutamine—Rash—Etoposide—brain cancer	0.000143	0.00228	CcSEcCtD
L-Glutamine—Dermatitis—Etoposide—brain cancer	0.000143	0.00228	CcSEcCtD
L-Glutamine—Headache—Etoposide—brain cancer	0.000142	0.00226	CcSEcCtD
L-Glutamine—Nausea—Etoposide—brain cancer	0.000134	0.00215	CcSEcCtD
L-Glutamine—GMPS—Metabolism—BSG—brain cancer	0.000134	0.00489	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—BSG—brain cancer	0.000134	0.00489	CbGpPWpGaD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—TP53—brain cancer	0.000133	0.00484	CbGpPWpGaD
L-Glutamine—SLC1A5—Transmembrane transport of small molecules—TRPC6—brain cancer	0.00013	0.00474	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—IDH1—brain cancer	0.000129	0.00472	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—CYP2C9—brain cancer	0.000126	0.0046	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—CYP2C9—brain cancer	0.000126	0.0046	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—CYP2C9—brain cancer	0.000126	0.0046	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—IDH1—brain cancer	0.000126	0.00459	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—VAV1—brain cancer	0.000123	0.00449	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—BSG—brain cancer	0.000123	0.00447	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—HEY1—brain cancer	0.000119	0.00435	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—DLL1—brain cancer	0.000117	0.00427	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—IDH1—brain cancer	0.000115	0.0042	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—IDH1—brain cancer	0.000115	0.0042	CbGpPWpGaD
L-Glutamine—SLC38A3—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000111	0.00403	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—IDH1—brain cancer	0.00011	0.00401	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—BSG—brain cancer	0.000107	0.00391	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—BSG—brain cancer	0.000107	0.00391	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—BSG—brain cancer	0.000107	0.00391	CbGpPWpGaD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—IL2—brain cancer	0.000107	0.00389	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—IDH1—brain cancer	0.000105	0.00385	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—DNMT1—brain cancer	0.000104	0.00381	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—HEY1—brain cancer	0.000104	0.00381	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—S100A10—brain cancer	0.000103	0.00374	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—DLL1—brain cancer	0.000102	0.00373	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—ENO2—brain cancer	0.000102	0.00373	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—CYP2C9—brain cancer	0.000102	0.00371	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—SHH—brain cancer	9.95e-05	0.00363	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—ENO2—brain cancer	9.95e-05	0.00363	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—TRPC6—brain cancer	9.43e-05	0.00344	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—ESR2—brain cancer	9.38e-05	0.00342	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—CYP2C9—brain cancer	9.29e-05	0.00339	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—IDH1—brain cancer	9.22e-05	0.00336	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—IDH1—brain cancer	9.22e-05	0.00336	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—IDH1—brain cancer	9.22e-05	0.00336	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—ENO2—brain cancer	9.11e-05	0.00332	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—ENO2—brain cancer	9.11e-05	0.00332	CbGpPWpGaD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—VEGFA—brain cancer	9.07e-05	0.00331	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—NOTCH2—brain cancer	8.88e-05	0.00324	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—ENO2—brain cancer	8.7e-05	0.00317	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—SHH—brain cancer	8.7e-05	0.00317	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—BSG—brain cancer	8.64e-05	0.00315	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—ENO2—brain cancer	8.34e-05	0.00304	CbGpPWpGaD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—TRPC6—brain cancer	8.17e-05	0.00298	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—BSG—brain cancer	7.9e-05	0.00288	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—PIK3CG—brain cancer	7.82e-05	0.00285	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—SIRT1—brain cancer	7.55e-05	0.00275	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—IDH1—brain cancer	7.43e-05	0.00271	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—ENO2—brain cancer	7.29e-05	0.00266	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—ENO2—brain cancer	7.29e-05	0.00266	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—ENO2—brain cancer	7.29e-05	0.00266	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—CYP2C9—brain cancer	7.24e-05	0.00264	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—CYP2C9—brain cancer	7.24e-05	0.00264	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—VAV1—brain cancer	7.19e-05	0.00262	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—VAV1—brain cancer	7.07e-05	0.00258	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—IDH1—brain cancer	6.8e-05	0.00248	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—VAV1—brain cancer	6.29e-05	0.00229	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—HES1—brain cancer	6.18e-05	0.00226	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—BSG—brain cancer	6.16e-05	0.00225	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—BSG—brain cancer	6.16e-05	0.00225	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PDGFRA—brain cancer	5.89e-05	0.00215	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—ENO2—brain cancer	5.87e-05	0.00214	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—IL2—brain cancer	5.5e-05	0.00201	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—HES1—brain cancer	5.41e-05	0.00197	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—ENO2—brain cancer	5.37e-05	0.00196	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—IDH1—brain cancer	5.29e-05	0.00193	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—IDH1—brain cancer	5.29e-05	0.00193	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—IRS2—brain cancer	5.17e-05	0.00189	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PDGFRA—brain cancer	5.15e-05	0.00188	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—TRPC6—brain cancer	4.74e-05	0.00173	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PIK3CG—brain cancer	4.69e-05	0.00171	CbGpPWpGaD
L-Glutamine—GFPT2—Metabolism of proteins—CTNNB1—brain cancer	4.69e-05	0.00171	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—VEGFA—brain cancer	4.67e-05	0.0017	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—APC—brain cancer	4.57e-05	0.00167	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—IRS2—brain cancer	4.52e-05	0.00165	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—PIK3CG—brain cancer	4.49e-05	0.00164	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ENO2—brain cancer	4.18e-05	0.00153	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ENO2—brain cancer	4.18e-05	0.00153	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PIK3CG—brain cancer	4.18e-05	0.00152	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PIK3CG—brain cancer	4.18e-05	0.00152	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—APC—brain cancer	3.99e-05	0.00146	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PIK3CG—brain cancer	3.82e-05	0.00139	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—ERBB2—brain cancer	3.55e-05	0.00129	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—TP53—brain cancer	3.53e-05	0.00129	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PIK3CG—brain cancer	3.34e-05	0.00122	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PIK3CG—brain cancer	3.34e-05	0.00122	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PIK3CG—brain cancer	3.34e-05	0.00122	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—IL2—brain cancer	3.16e-05	0.00115	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—CTNNB1—brain cancer	3.1e-05	0.00113	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—ERBB2—brain cancer	3.1e-05	0.00113	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—MYC—brain cancer	2.96e-05	0.00108	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—CTNNB1—brain cancer	2.71e-05	0.000989	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—STAT3—brain cancer	2.7e-05	0.000986	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PIK3CG—brain cancer	2.69e-05	0.000983	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—VEGFA—brain cancer	2.68e-05	0.000979	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—CTNNB1—brain cancer	2.53e-05	0.000923	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MYC—brain cancer	2.51e-05	0.000916	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PIK3CG—brain cancer	2.46e-05	0.000899	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—EGFR—brain cancer	2.46e-05	0.000896	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—STAT3—brain cancer	2.36e-05	0.000862	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MYC—brain cancer	2.2e-05	0.000801	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—EGFR—brain cancer	2.15e-05	0.000783	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—TP53—brain cancer	2.03e-05	0.00074	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PIK3CG—brain cancer	1.92e-05	0.0007	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PIK3CG—brain cancer	1.92e-05	0.0007	CbGpPWpGaD
